Health security

Valeant Pharmaceutics Raised Prices on Needed Drugs, Then Its Stock Took a Hit

Valeant Pharmaceuticals International Inc. and its billionaire boss Michael Pearson have been the subject of some bad press lately, and since then, the company’s stock has taken a tumble.

Some, such as The Wall Street Journal, are bound to chalk this news up to the magical equalizing powers of capitalism’s famous ‘invisible hand,’ while others might point to the democratizing sting of actual journalism as the more potent force in this mix (both might be the stuff of myth these days). Here’s the WSJ’s account, as of Monday:

Shares of Valeant Pharmaceuticals International Inc.VRX.T +1.55% continued their slide Monday, falling more than 10%.